Not logged in Share Save
Share Save
Share Save
Ocrelizumab in Early-Stage Relapsing-Remitting Multiple Sclerosis Hartung, Hans-Peter; Benedict, Ralph H. B.; Berger, Thomas; Bermel, Robert A.; Brochet, Bruno; Carroll, William M.; Freedman, Mark S.; Holmoy, Trygve; Karabudak, Rana; Nos, Carlos; Patti, Francesco; Perrin Ross, Amy; Vanopdenbosch, Ludo; Vollmer, Timothy; Wuerfel, Jens; Clinch, Susanne; Kadner, Karen; Kuenzel, Thomas; Kulyk, Inessa; Raposo, Catarina; Thanei, Gian-Andrea; Killestein, Joep Share Save
Different Treatment Outcomes of Multiple Sclerosis Patients Receiving Ocrelizumab or Ofatumumab Meuth, Sven G.; Wolff, Stephanie; Mueck, Anna; Willison, Alice; Kleinschnitz, Konstanze; Raeuber, Saskia; Pawlitzki, Marc; Konen, Franz Felix; Skripuletz, Thomas; Grothe, Matthias; Ruck, Tobias; Huttner, Hagen B.; Kleinschnitz, Christoph; Bopp, Tobias; Pul, Refik; Cree, Bruce A. C.; Hartung, Hans-Peter; Moellenhoff, Kathrin; Pfeuffer, Steffen Share Save
Share Save
Challenges in monitoring the quality of care in multiple sclerosis - authors ' reply Voigt, Isabel; Fischer, Stefanie; Proschmann, Undine; Konofalska, Urszula; Richter, Peggy; Schlieter, Hannes; Berger, Thomas; Meuth, Sven G.; Hartung, Hans-Peter; Akguen, Katja; Ziemssen, Tjalf Share Save
Evolution of retinal degeneration and prediction of disease activity in relapsing and progressive multiple sclerosis Kraemer, Julia; Balloff, Carolin; Weise, Margit; Koska, Valeria; Uthmeier, Yannik; Esderts, Isabell; Nguyen-Minh, Mai; Zimmerhof, Moritz; Hartmann, Alex; Dietrich, Michael; Ingwersen, Jens; Lee, John-Ih; Havla, Joachim; Kuempfel, Tania; Kerschensteiner, Martin; Haeussler, Vivien; Heesen, Christoph; Stellmann, Jan-Patrick; Zimmermann, Hanna G.; Oertel, Frederike C.; Ringelstein, Marius; Brandt, Alexander U.; Paul, Friedemann; Aktas, Orhan; Hartung, Hans-Peter; Wiendl, Heinz; Meuth, Sven G.; Albrecht, Philipp Share Save
Inter-alpha-trypsin inhibitor heavy chain H3 is a potential biomarker for disease activity in myasthenia gravis Schroeter, Christina B.; Nelke, Christopher; Stascheit, Frauke; Huntemann, Niklas; Preusse, Corinna; Dobelmann, Vera; Theissen, Lukas; Pawlitzki, Marc; Raeuber, Saskia; Willison, Alice; Vogelsang, Anna; Marina, Adela Della; Hartung, Hans-Peter; Melzer, Nico; Konen, Felix F.; Skripuletz, Thomas; Hentschel, Andreas; Koenig, Simone; Schweizer, Michaela; Stuehler, Kai; Poschmann, Gereon; Roos, Andreas; Stenzel, Werner; Meisel, Andreas; Meuth, Sven G.; Ruck, Tobias Share Save
Temporal Relationship Between Serum Neurofilament Light Chain and Radiologic Disease Activity in Patients With Multiple Sclerosis Fox, Robert J.; Cree, Bruce A. C.; de Seze, Jerome; Gold, Ralf; Hartung, Hans-Peter; Jeffery, Douglas; Kappos, Ludwig; Montalban, Xavier; Weinstock-Guttman, Bianca; Singh, Carol M.; Altincatal, Arman; Belviso, Nicholas; Avila, Robin L.; Ho, Pei-Ran; Su, Ray; Engle, Robert; Sangurdekar, Dipen; de Moor, Carl; Fisher, Elizabeth; Kieseier, Bernd C.; Rudick, Richard A. Share Save
Efficacy, safety and tolerability of rozanolixizumab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a randomised, subject-blind, investigator-blind, placebo-controlled, phase 2a trial and open-label extension study Querol, Luis; De Seze, Jerome; Dysgaard, Tina; Levine, Todd; Rao, T. Hemanth; Rivner, Michael; Hartung, Hans-Peter; Kiessling, Peter; Shimizu, Saori; Marmol, Dominika; Bozorg, Ali; Colson, Anny-Odile; Massow, Ute; Eftimov, Filip Share Save
Consensus quality indicators for monitoring multiple sclerosis Voigt, Isabel; Fischer, Stefanie; Proschmann, Undine; Konofalska, Urszula; Richter, Peggy; Schlieter, Hannes; Berger, Thomas; Meuth, Sven G.; Hartung, Hans-Peter; Akguen, Katja; Ziemssen, Tjalf Share Save
Share Save
Recombinant Acetylcholine Receptor Immunization Induces a Robust Model of Experimental Autoimmune Myasthenia Gravis in Mice Theissen, Lukas; Schroeter, Christina B.; Huntemann, Niklas; Raeuber, Saskia; Dobelmann, Vera; Cengiz, Derya; Herrmann, Alexander; Koch-Hoelsken, Kathrin; Gerdes, Norbert; Hu, Hao; Mourikis, Philipp; Polzin, Amin; Kelm, Malte; Hartung, Hans-Peter; Meuth, Sven G.; Nelke, Christopher; Ruck, Tobias Share Save
Concurrent administration of serotonergic antidepressants and ozanimod in participants with relapsing multiple sclerosis from the open-label extension DAYBREAK trial Naismith, Robert T.; Cohen, Jeffrey A.; Bar-Or, Amit; Comi, Giancarlo; Selmaj, Krzysztof W.; Hartung, Hans-Peter; Sheffield, James K.; Krakovich, Anthony; Tatosian, Daniel; Cheng, Chun-Yen; Reardon, Jennifer; Khaychuk, Vadim; Riolo, Jon, V; Silva, Diego; Cree, Bruce A. C. Share Save
Share Save
Inebilizumab reduces neuromyelitis optica spectrum disorder risk independent of FCGR3A polymorphism Kim, Ho Jin; Aktas, Orhan; Patterson, Kristina R.; Korff, Schaun; Kunchok, Amy; Bennett, Jeffrey L.; Weinshenker, Brian G.; Paul, Friedemann; Hartung, Hans-Peter; Cimbora, Daniel; Smith, Michael A.; Mittereder, Nanette; Rees, William A.; She, Dewei; Cree, Bruce A. C. Share Save
Transgenic expression of the HERV-W envelope protein leads to polarized glial cell populations and a neurodegenerative environment Gruchot, Joel; Lewen, Isabel; Dietrich, Michael; Reiche, Laura; Sindi, Mustafa; Hecker, Christina; Herrero, Felisa; Charvet, Benjamin; Weber-Stadlbauer, Ulrike; Hartung, Hans-Peter; Albrecht, Philipp; Perron, Herve; Meyer, Urs; Kuery, Patrick Share Save
SARS-CoV-2 vaccination and infection in ozanimod-treated participants with relapsing multiple sclerosis Cree, Bruce A. C.; Maddux, Rachel; Bar-Or, Amit; Hartung, Hans-Peter; Kaur, Amandeep; Brown, Elizabeth; Li, Yicong; Hu, Yanhua; Sheffield, James K.; Silva, Diego; Harris, Sarah Share Save
Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
